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Introduction
Skeletal muscle has a remarkable capacity to respond to path-
ological stress and regenerate upon injury. Skeletal muscle 
consists of postmitotic, multinucleated myofibers as well as 
mononuclear cells, including muscle progenitor cells (satel-
lite cells) and other less well-characterized interstitial cells. 
Muscle regeneration is dependent on satellite cells, which in 
response to injury undergo proliferation, differentiation, and 
ultimately, fusion with new or existing myofibers to repair the 
muscle. Recently, the importance of other cell types located 
within the muscle interstitium has gained interest. Many of 
these, such as muscle side population (SP) cells, PW1+/Pax7 
cells, vascular-associated pericytes, and myoendothelial cells 
have been reported to possess myogenic potential (Asakura   
et al., 2002; Dellavalle et al., 2007; Zheng et al., 2007; Tanaka 
et al., 2009 Mitchell et al., 2010). Others, including endothelial 
cells and fibroadipogenic progenitors (FAPs), positively regu-
late myogenesis (Abou-Khalil et al., 2010; Joe et al., 2010). 
In addition to these resident muscle cells, substantial evidence 
suggests regulatory interactions of the immune response with 
skeletal muscle play a significant role in regeneration (Tidball 
and Villalta, 2010).
Previous studies suggest that muscle SP cells may be pre-
cursors of the satellite cell population or may be independent 
progenitor cells that participate in muscle regeneration. The SP 
phenotype is defined by the ability of cells to efflux Hoechst 
33342  dye.  Abcg2,  a  member  of  the  ATP-binding  cassette 
(ABC) transporter family, effluxes Hoechst 33342 dye and is 
the molecular determinant of the SP phenotype (Zhou et al., 
2001). Abcg2 also confers drug resistance in tumor cells by   
actively exporting multiple drugs and protects cells from apopto-
sis under cases of hypoxia and oxidative stress (Krishnamurthy 
et al., 2004; Krishnamurthy and Schuetz, 2006; Martin et al., 
2008).  Multiple  tissues,  including  muscle,  contain  SP  cells 
positive for Abcg2. In adult skeletal muscle, Abcg2-positive 
cells are closely localized to the vasculature (Meeson et al., 
2004; Huls et al., 2009). Although previous studies show that 
muscle SP cells engraft into regenerating myofibers upon   
intramuscular transplantation (Asakura et al., 2002; Meeson   
et al., 2004; Tanaka et al., 2009), the fate of endogenous 
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keletal  muscle  contains  progenitor  cells  (satellite   
cells) that maintain and repair muscle. It also con-
tains muscle side population (SP) cells, which ex-
press Abcg2 and may participate in muscle regeneration 
or may represent a source of satellite cell replenishment. 
In  Abcg2-null  mice,  the  SP  fraction  is  lost  in  skeletal 
muscle, although the significance of this loss was pre-
viously unknown. We show that cells expressing Abcg2 
increased upon injury and that muscle regeneration was 
impaired in Abcg2-null mice, resulting in fewer centrally 
nucleated myofibers, reduced myofiber size, and fewer 
satellite cells. Additionally, using genetic lineage tracing, 
we demonstrate that the progeny of Abcg2-expressing 
cells contributed to multiple cell types within the muscle   
interstitium, primarily endothelial cells. After injury, Abcg2 
progeny made a minor contribution to regenerated myo-
fibers. Furthermore, Abcg2-labeled cells increased sig-
nificantly upon injury and appeared to traffic to muscle 
from peripheral blood. Together, these data suggest an 
important role for Abcg2 in positively regulating skeletal 
muscle regeneration.
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of Abcg2 loss during skeletal muscle regeneration by assessing 
regeneration of the TA muscle after injury with 1.2% BaCl2. 
Before injury, we observed no significant histological defects   
in the TA muscle of Abcg2
/ mice (Fig. 2 A). Regeneration 
appears delayed in Abcg2
/ mice at 3 and 5 d after injury.   
Although Abcg2
/ mice appear to recover 12 d after injury, the 
persistence of small myofibers suggests that regeneration of 
new myofibers is still underway (Fig. 2 A). By 30 d after injury, 
the overall tissue architecture is restored, whereas the number 
of centrally nucleated myofibers, a hallmark of regeneration, as 
well as the total number of myonuclei in the TA muscle of 
Abcg2
/ mice is reduced compared with wild-type littermates 
(Fig. 2, B and C). On average, 60% of myofibers in Abcg2
/ 
injured muscles are centrally nucleated compared with 84% of 
centrally nucleated myofibers in injured muscles of wild-type 
mice. A significant number of smaller caliber myofibers remain, 
whereas large myofibers are lost in Abcg2
/ muscle (Fig. 2 D), 
as demonstrated by the a reduced mean myofiber cross-sectional 
area of 1,627 µm
2 in Abcg2
/ TA muscles compared with 
2,407 µm
2 in wild-type TA muscles. Fewer centrally nucleated 
myofibers and smaller myofiber area in Abcg2
/ mice indicate 
impaired muscle regeneration.
To further understand the regeneration defects in Abcg2
/ 
mice, we assessed the expression of embryonic myosin heavy 
chain (MyHC; eMyHC) as an indicator of early myogenesis 
and the extent of BrdU uptake to indicate the proliferation status   
of cells at 5 d after BaCl2-induced injury. Fewer eMyHC-positive   
myofibers are present in Abcg2
/ muscle compared with wild- 
type muscle (Fig. 3 A). In Abcg2
/ mice, fewer cells have 
incorporated BrdU into their DNA (51 compared with 75 
BrdU-positive cells per field), indicating that fewer cells are 
proliferating  (Fig.  3,  B–D).  Interestingly,  BrdU-positive  nuclei 
found within laminin-positive regenerating myofibers (intra-
laminar)  compared  with  extralaminar  BrdU-positive  cells 
are more greatly reduced in Abcg2
/ muscle than wild-type 
muscle, indicating that proliferation of myogenic cells is more 
significantly affected than nonmyogenic cells (Fig. 3 D). This 
decrease in cycling myogenic cells is consistent with the de-
crease in the total number of myonuclei observed at 30 d after 
injury (Fig. 2 C). Furthermore, although the number of Pax7+ 
satellite cells found under the basal lamina is similar in un-
injured mice, 30% fewer Pax7+ satellite cells are observed at   
30 d after injury in the muscle of Abcg2
/ mice compared with 
wild-type mice (Fig. 3 E). The loss of Pax7+ cells at 30 d after 
injury suggests a decreased ability to replenish the satellite cell 
pool in Abcg2
/ mice.
A possible mechanism leading to the regeneration de-
fects and loss of satellite cells we observe in Abcg2
/ muscle 
is an inherent defect in the ability of satellite cells to undergo 
myogenesis in response to injury. To test this possibility, we 
isolated satellite cells from the hind limbs of Abcg2
/ and 
wild-type littermate mice and assayed their myogenic poten-
tial in vitro. We observed no significant difference in clone 
size, number of Pax7- or MyoD-positive cells, or in the fusion 
index (Table I and Fig. S1). By 3 d in culture, 80% of myo-
nuclei are MyoD positive, and 40% are in multinucleated 
myotubes, which increases to nearly 70% after 5 d in culture. 
muscle SP cells has not been traced in vivo, and so much about 
their identity and potential remains unknown. Upon genetic 
deletion of Abcg2, muscle SP cells are lost (Zhou et al., 2002), 
although the consequence of this loss on muscle regeneration 
has not been tested.
In the present study, we analyze the functional conse-
quence of germline deletion of Abcg2 on muscle regeneration 
and show that muscle regeneration is delayed, resulting in fewer 
myonuclei and smaller caliber myofibers as well as a decrease 
in Pax7-positive satellite cells. Additionally, we followed the 
fate of Abcg2-positive cells in skeletal muscle in vivo using 
genetic lineage tracing driven by Abcg2 expression. Using this 
approach, we demonstrate that Abcg2-labeled cells contribute 
primarily to vascular-associated interstitial cells, including endo-
thelial cells and pericytes. Upon injury, Abcg2-labeled progeny 
increases, although under these conditions, they are not a major 
contributor to myonuclei. We further show that the immune re-
sponse is compromised in Abcg2
/ mice after injury. These 
data suggest that Abcg2 function in nonmyogenic cells affects 
signaling that positively regulates myogenesis.
Results
Expression of Abcg2 increases upon 
muscle injury
Expression of Abcg2 has been previously reported in progenitor 
cells isolated from skeletal muscle (Meeson et al., 2004; Tanaka 
et al., 2009). To determine whether Abcg2 expression is dy-
namically regulated during muscle regeneration, we isolated 
mononuclear cells from the tibialis anterior (TA) muscle of 
mice injured with 1.2% BaCl2 at 2, 5, 12, and 30 d after injury 
as well as from uninjured TA muscles and analyzed the cells via 
flow cytometry for Abcg2 expression. We observed that in rest-
ing muscle, 22% of mononuclear cells express Abcg2 (Fig. 1,   
A  and  F).  The  mean  percentage  of  muscle  cells  expressing 
Abcg2 increases significantly between 2 and 5 d after injury 
from 20 to 39% of isolated cells (Fig. 1, B, C, and F). At 12 d   
after injury, the percentage of cells expressing Abcg2 begins 
to decline, reaching levels similar to those of uninjured tis-
sue by 30 d after injury (Fig. 1, D–F). The increase in Abcg2- 
expressing cells at 5 d after injury is consistent with the reported 
increase seen in tissue sections after cardiotoxin-induced injury 
(Meeson et al., 2004). The dynamic change in the relative num-
ber of cells expressing Abcg2 coincides with the timing of both 
the inflammatory response and myoblast expansion.
Muscle regeneration is impaired in  
Abcg2
/ mice
Cells exhibiting the potential to generate myonuclei upon intra-
muscular transplantation have previously been identified in the 
muscle SP (Asakura et al., 2002; Tanaka et al., 2009). Addition-
ally, Abcg2 is an important determinant of the SP phenotype, 
and muscle SP cells are lost in Abcg2-null (Abcg2
/) mice 
(Zhou et al., 2001, 2002). These data together with the observa-
tion that Abcg2-positive cells increase significantly upon mus-
cle injury suggest an important function for Abcg2 during muscle 
regeneration. Therefore, we tested the functional consequence 149 Abcg2 lineage tracing in skeletal muscle • Doyle et al.
CreERT2 fusion protein can be temporally controlled using 
systemically  delivered  tamoxifen.  Adult  Abcg2
CreERT2;R26R 
mice were treated with tamoxifen for a consecutive 3 d, and 
uninjured TA muscles were analyzed for expression of the   
-galactosidase reporter protein at 6, 14, or 30 d after tamoxi-
fen treatment. -galactosidase activity is detected in a small 
number of interstitial cell types at 6 d after treatment (Fig. 4, 
A and E). The number of labeled cells increases at 14 d and 
reaches a peak at 30 d after tamoxifen treatment in uninjured 
muscle (Fig. 4, B, C, and E). In the TA muscle of untreated 
mice, no -galactosidase activity was detected (Fig. 4 D). In 
uninjured muscle, we did not detect -galactosidase staining in 
muscle fibers. Costaining for -galactosidase and laminin on 
muscle sections showed that -galactosidase–positive cells are 
excluded from the myofibers, confirming that interstitial cells 
are labeled by Abcg2 lineage tracing (Fig. 4 F). The increase in 
labeled cells over time after tamoxifen treatment suggests that 
Abcg2 labels a cell population in uninjured muscle that sub-
sequently proliferates and contributes significantly to muscle 
interstitial cell types.
Because  regeneration  is  impaired  in  Abcg2
/  muscle   
after BaCl2-induced injury, and Abcg2 expression has been 
correlated with progenitor cells capable of forming myotubes   
Together, these data indicate that satellite cells isolated from 
Abcg2
/ mice proliferate and differentiate at rates similar to 
wild-type cells, and therefore, the satellite cells show no de-
tectable cell-autonomous defects.
Abcg2 labels interstitial cells in  
skeletal muscle
Because we did not observe cell-autonomous defects in sat-
ellite cells, yet the percentage of Abcg2-expressing cells in-
creases upon injury, we used genetic lineage tracing to identify 
cell progeny that arise from Abcg2-marked cells within skeletal 
muscle. To genetically lineage trace Abcg2-positive cells, we 
used a tamoxifen-inducible Cre-lox reporter system to label and 
follow the progeny of Abcg2-positive cells. A targeted knockin   
mouse  expressing  the  Cre  recombinase  ER  ligand  binding   
domain fusion protein (CreERT2) from the Abcg2 locus was 
generated by inserting an internal ribosomal entry site–CreERT2 
construct into the 3 untranslated region of the endogenous 
Abcg2 gene, resulting in expression of wild-type Abcg2 and the 
CreERT2 fusion gene (unpublished data). Abcg2
CreERT2 mice 
were crossed with 129S-Gt(Rosa)26Sor
tm1Sor/J mice (referred 
to as R26R), which carry the LacZ reporter gene downstream 
of a loxP-flanked stop codon (Soriano, 1999). Activity of the 
Figure 1.  Mononuclear cells expressing Abcg2 increase after BaCl2-induced injury. (A–E) Representative dot plots show Abcg2-positive cells versus side 
scatter with gate set to <1% false positives, isolated from uninjured (UI) TA muscle or 2, 5, 12, and 30 d postinjury (dpi) with BaCl2. (B and F) Cells ex-
pressing Abcg2 peak at 5 days after injury (*, P < 0.01). Boxed regions indicate the percentage of cells positive for Abcg2. (F) Graph shows the mean 
percentages ± SEM of Abcg2-positive cells for each time point analyzed (minimum of five mice per time point).JCB • VOLUME 195 • NUMBER 1 • 2011   150
Figure 2.  Regeneration is impaired in Abcg2
/ mice compared with wild-type mice. (A) Hematoxylin and eosin staining of uninjured TA muscles and TA 
muscles harvested at 3, 5, 12, and 30 d after injury. Hematoxylin and eosin–stained sections show delayed regeneration (day 3 and 5), fewer centrally 
nucleated myofibers (day 5 and 30), and reduced fiber size (day 12 and 30) in Abcg2
/ muscle. Bar, 50 µm. (B–D) Quantification of the reduced number 
of centrally nucleated myofibers (***, P < 0.001; B), reduced total myonuclei per fiber (**, P = 0.0019; C), and reduced myofiber area (D) at 30 d after 
injury are shown; mean cross-sectional area for wild-type (WT) myofibers is 2,407 µm
2 and Abcg2
/ myofibers is 1,627 µm
2 (P < 0.001). All values are 
means ± SEM. A minimum of 500 myofibers and three sections were analyzed for three mice per genotype. KO, knockout.151 Abcg2 lineage tracing in skeletal muscle • Doyle et al.
Figure 3.  Myogenesis and cell proliferation is disrupted in Abcg2
/ mice. (A and B) Fewer eMyHC-expressing myofibers (green; A) and fewer BrdU- 
positive cells (green; B) are found in Abcg2
/ muscles at 5 d after injury compared with wild-type (WT) muscles. Bars, 50 µm. (C) Magnification of boxed 
regions in B. Bar, 10 µm. Nuclei are stained with DAPI. (D) The number of BrdU-positive cells per field is shown as means ± SEM for intralaminar (within 
laminin-positive regenerating myofibers; **, P < 0.01), extralaminar (P = 0.4), and total BrdU-positive cells (**, P < 0.01). n = 3 mice per genotype.   
(E) The number of Pax7-positive sublaminar cells per field is shown for uninjured (UI) and 30 d after injury TAs (***, P < 0.001 at 30 d postinjury [dpi]).   
Means ± SEM; n = 4 mice per genotype. KO, knockout.JCB • VOLUME 195 • NUMBER 1 • 2011   152
number of regenerated myofibers (Fig. 5 C and Fig. S2 B). We 
observed clusters of 1–8 positive myofibers in the TA muscle of 
5 out of 11 mice injured concurrently with tamoxifen treatment. 
The punctate staining pattern we observe is consistent with the 
cytoplasmic localization of the LacZ gene when low levels of 
LacZ are expressed from the Rosa locus and similar to the   
staining pattern observed in muscle fibers of Actin
CreERT2;R26R 
mice upon low levels of Cre-mediated recombination (Fig. S2 B). 
These results demonstrate that endogenous Abcg2-labeled 
cells  can  contribute  to  myofibers,  but  this  contribution  is   
minor in vivo using our injury/labeling procedure. Interestingly, 
Abcg2 marks 60% of interstitial cells regardless of whether 
the  TA  muscle  was  injured  or  when  it  was  injured  relative   
to tamoxifen treatment (Fig. 5 E). Furthermore, when we bred 
Abcg2
CreERT2;R26R  to  the  mdx
4cv  mouse  (mouse  model  of 
in vitro under some conditions and contributing to myofiber re-
generation upon transplantation into injured muscle (Meeson   
et al., 2004; Tanaka et al., 2009), we reasoned that Abcg2 progeny 
would contribute to newly formed myofibers after injury. To test 
this hypothesis, we injured Abcg2
CreERT2;R26R mice with 1.2% 
BaCl2 at various time points relative to tamoxifen injection and 
assessed the contribution of -galactosidase–positive cells to   
regenerated myofibers at 30 d after injury. In the uninjured TA 
muscle 30 d after tamoxifen treatment, no -galactosidase stain-
ing is detected in myofibers (Fig. 5 A and Fig. 4 C). Although an 
induced injury performed 14 d after tamoxifen treatment yielded 
no detectable -galactosidase staining in regenerated (centrally 
nucleated) myofibers (Fig. 5 B), an injury induced concurrently 
with tamoxifen treatment (at the time of the second tamoxifen 
injection) yielded detectable -galactosidase activity in a small 
Table I.  Abcg2
/ satellite cells exhibit no cell-autonomous defects
Genotype Colony size Pax7+ cells MyoD+ cells Fusion index
Day 2 Day 3 Day 3 Day 3 Day 5
Number of cells % % % %
Abcg2
+/+ 41 ± 5 57.9 ± 3.6 78.2 ± 3.0 39.0 ± 2.6 65.7 ± 2.2
Abcg2
/ 33 ± 4 48.8 ± 3.7 83.9 ± 2.6 36.9 ± 2.1 67.6 ± 2.2
The number of nuclei in multinucleated MyHC-positive myotubes per total myonuclei was scored (fusion index). Values are means ± SEM. n = 3 independent experiments.
Figure 4.  Interstitial cell types are labeled by an Abcg2-driven CreERT2 and increase over time. (A–C) X-gal staining of uninjured TA muscles at 6 d (A),   
14 d (B), and 30 d (C) after tamoxifen treatment show labeling of interstitial cells that increase over time. (D) TA muscle sections from untreated mice 
show no detectable X-gal staining. (A–C and E) Magnification of A–C (A–C) and quantification of -galactosidase (-gal)–positive cells (E) are shown.   
Means ± SEM; n = 3 mice per time point. (F) Immunoreactivity of -galactosidase and laminin antibodies confirms that labeled cells are excluded from the 
myofiber. Nuclei are stained with DAPI (blue). Arrowheads indicate -galactosidase–positive cells. Bars, 50 µm.153 Abcg2 lineage tracing in skeletal muscle • Doyle et al.
Because Abcg2-marked cells predominately contribute to inter-
stitial cells, and satellite cell–derived cultures from Abcg2
/ 
mice display no detectable defects, yet regeneration is impaired 
in Abcg2
/ mice, we hypothesized that Abcg2-marked inter-
stitial cells indirectly support myogenesis. To better understand 
which cell types are labeled by Abcg2, we undertook a thor-
ough analysis of the cells marked by Abcg2 lineage tracing in 
uninjured muscle. Our previous analysis indicated that many 
cells coexpress Abcg2 and Sca-1 (stem cell antigen 1), so we 
assessed the expression of Sca-1 within Abcg2-labeled prog-
eny. Sca-1 is widely expressed by progenitor populations in 
multiple tissues and many muscle interstitial cell types, includ-
ing FAPs and CD31-positive endothelial cells (Tamaki et al., 
2002; Mitchell et al., 2005; Joe et al., 2010). By immunofluores-
cence using anti–-galactosidase antibodies, -galactosidase   
is widely colocalized in cells expressing Sca-1 (Fig. 6 A) as 
Duchenne muscular dystrophy; Im et al., 1996), we did not de-
tect contribution from Abcg2-labeled cells to myofibers in the 
mdx
4cv mouse (Fig. 5 D), suggesting Abcg2-labeled cells do not 
contribute directly to muscle regeneration in a model of chronic 
muscle damage.
Abcg2 progeny include multiple interstitial 
cell types
Cells located in the interstitium include several cell types that 
either possess myogenic potential or indirectly and positively 
regulate myogenesis (Péault et al., 2007; Abou-Khalil et al., 
2010). Among these cells are vascular-associated cells, includ-
ing endothelial cells and pericytes, FAPs, muscle SP cells, and 
PW1+/Pax7 interstitial cells (Asakura et al., 2002; Tamaki 
et al., 2002; Meeson et al., 2004; Dellavalle et al., 2007; Joe   
et  al.,  2010;  Mitchell  et  al.,  2010;  Uezumi  et  al.,  2010).   
Figure 5.  Abcg2 progeny do not contribute significantly to myofiber regeneration. (A–C) X-gal staining of tissue sections from uninjured TA muscle 30 d 
after tamoxifen treatment (A), 30 d postinjury (dpi) TA muscle injured 14 d after tamoxifen treatment (n = 10; B), or during tamoxifen treatment (n = 11; C).   
Arrows indicate two fibers with punctate -galactosidase staining. (C) 1–8 positive myofibers per section in five of 11 mice analyzed are -galactosidase 
positive. (D) TA muscle from Abcg2
CreERT2;R26R mice crossed to mdx
4cv mice show no -galactosidase–positive myofibers (n = 4). Schematic shows 
time line of tamoxifen treatment, injury time point, and time of analysis. The time of injury is indicated as day 1 (stars in B and C). (E) The number of   
-galactosidase–positive cells as a percentage of total interstitial cells is shown as mean percentage ± SEM for uninjured (UI; bar A), 30 dpi injured at 
14 d after tamoxifen treatment (gray bar; bar B), or 30 d after injury injured during tamoxifen treatment (black bar; bar C) TA muscles (n = 3 mice per 
condition). Bar, 50 µm.JCB • VOLUME 195 • NUMBER 1 • 2011   154
progenitors and FAPs found in muscles have been reported (Joe 
et al., 2010; Uezumi et al., 2010). We determined that although 
the  majority  of  FDG-positive  and  CD45  and  CD31  double-
negative  cells  express  PDGF-R-,  few  are  also  positive  for 
Sca-1, indicating that <1% of total FDG-positive cells are FAPs   
(Fig. 7 E and Table II).
Abcg2 is expressed by stem cells in bone marrow as 
well as skeletal muscle (Zhou et al., 2001), and bone mar-
row cells positive for CD45 (a hematopoietic cell lineage 
marker) have been shown to traffic to skeletal muscle (Rivier 
et al., 2004). Therefore, we determined whether Abcg2 prog-
eny were CD45 positive and observed that <10% of FDG- 
positive cells are also positive for CD45 in uninjured muscle 
(Fig. 7 F and Table II). Within the FDG-positive, CD45-negative 
fraction of cells, 20% are Sca1 and CD34 double positive. 
It remains unclear what this small fraction of cells exactly 
is, as expression of Sca-1 and CD34 has been associated with 
numerous progenitor populations, including muscle SP cells, 
muscle-derived stem cells, and myoendothelial cells (Tamaki 
et al., 2002; Péault et al., 2007). Together, these data suggest 
well as in endothelial cells expressing the cell surface antigen 
CD31 (Pecam-1; Fig. 6 B). We also observe colocalization of 
-galactosidase with the proteoglycan NG2, a marker of peri-
cytes (Fig. 6 C; Dellavalle et al., 2007).
To quantify this coexpression, we took advantage of 
the fluorescent -galactosidase substrate fluorescein di--d- 
galactopyranoside (FDG) to label Abcg2 progeny for analysis 
by flow cytometry. At 2 wk or longer after tamoxifen treatment, 
25% of mononuclear cells from uninjured hind-limb muscles 
are FDG positive (Fig. 7 A). In uninjured muscle, CD31-positive 
endothelial cells comprise >80% of FDG-positive cells (Fig. 7 B   
and Table II). The majority of these cells are also positive for 
the cell surface markers Sca-1 and 7-integrin (Fig. 7 C). We 
further considered the minority of FDG-positive cells that are 
negative for CD31 (Fig. 7 B). Myogenic cells have been char-
acterized as 7-integrin positive and/or CD34 positive within 
in the CD31-negative and Sca-1–negative fraction (Montarras 
et al., 2005; Sacco et al., 2008; Joe et al., 2010). Based on this 
combination, <1% of FDG-positive cells are myogenic pro-
genitors (Fig. 7, D and F; and Table II). Recently, adipogenic 
Figure 6.  -galactosidase expression colocalizes with markers of vascular-associated cells. (A–C) Confocal microscopy (z projections of eight focal 
planes) demonstrates that -galactosidase (-gal) colocalizes in cells with Sca-1 (A), CD31 (B), and NG2 (C). Nuclei are stained with DAPI (blue).   
(A and B) Insets show enlarged images of boxed regions. Note that in A, there are two cells marked by the dashed lines; the right cell is negative for both 
-galactosidase and Sca-1. Bars, 10 µm.155 Abcg2 lineage tracing in skeletal muscle • Doyle et al.
Figure 7.  -galactosidase–positive cells coexpress markers of muscle interstitial cell types. FDG was used to label live cells expressing -galactosidase 
isolated from hind-limb muscles followed by staining with fluorophore-conjugated antibodies for analysis by flow cytometry including Sca-1, CD31,   
7-integrin, CD45, CD34, and PDGF-R-. (A) Approximately 25% of cells detected from Abcg2
CreERT2;R26R mice treated with tamoxifen are FDG+ 
(A, gated region). Less than 1% of cells isolated from mice that had not received tamoxifen are FDG+ (gated region) similar to unlabeled cells. Analysis of 
FDG coexpression with various markers was performed by first gating for FDG and then the antibody of interest and are shown as described at the bottom. 
Gates are set to <1% positives on appropriate fluorescence minus one controls. (B) The majority of FDG+ cells are positive for the endothelial cell marker 
CD31 (blue box). (C) FDG+ and CD31+ (blue box in B) cells are gated onto a plot for 7-integrin versus Sca-1, showing that most CD31+ cells are also 
7-integrin+ and Sca-1+ (C, top right quadrant). (B and D) Similarly, FDG+ and CD31 (11%, red box in B) cells are gated onto a plot for 7-integrin 
versus Sca-1 showing 10% myogenic (7-integrin+ and Sca-1) cells (red box in D), indicating <1% of FDG+ cells are myogenic. (E) The CD45/CD31 
(7%, red box) fraction of FDG+ cells was gated onto a plot for PDGF-R- versus Sca-1, which shows most of these cells are PDGF-R-+ and Sca-1.   
(F) CD45+ cells make up <10% of FDG+ cells (blue box). The FDG+ and CD45 fraction (red box) is gated for CD34 versus Sca-1, which shows that 
20% are CD34+ and Sca1+ and may include other progenitor populations but few myogenic cells (CD34+ and Sca-1). Dot plots shown are representa-
tive of three to six independent experiments. APC, allophycocyanin; PE, phycoerythrin.JCB • VOLUME 195 • NUMBER 1 • 2011   156
macrophage marker F4/80 (Fig. 8 D). Therefore, the tran-
sient increase in Abcg2-labeled cells in injured muscle tissue 
likely derives from circulating hematopoietic cells. Collec-
tively, our data suggest that Abcg2-marked cells in muscle 
include  a  population  of  resident  interstitial  cells  (CD45 
negative in uninjured tissue) and a population of circulating 
cells that traffic to the muscle upon injury (CD45 positive), 
further supporting the hypothesis that Abcg2-positive cells 
positively contribute to muscle regeneration.
Immune response, but not angiogenesis, is 
affected in Abcg2
/ mice upon injury
The impaired regeneration phenotype in Abcg2
/ mice is 
not explained by cell-autonomous defects in satellite cells; 
however,  Abcg2  is  expressed  in  muscle  interstitial  cells 
types in uninjured tissue and infiltrates cells upon injury. It 
is becoming appreciated that the cellular processes of angio-
genesis and the inflammatory response precede myogenesis. 
Both of these cellular events positively regulate myogenesis 
(Abou-Khalil et al., 2010; Tidball and Villalta, 2010). There-
fore, we examined the angiogenic and immune responses at 
early time points after injury in Abcg2
/ muscle. The den-
sity of vasculature as assessed by CD31 and vascular endo-
thelial (VE) cadherin staining was unaffected in Abcg2
/ 
muscle at 5 d after injury (Fig. 9, A and B; and not depicted).   
Although there appears to be no significant defect in gen-
eration of new vasculature, signaling from endothelial cells 
could be impaired, so we analyzed the mRNA expression levels 
of several angiogenic signaling genes. We detect no differ-
ences in uninjured muscle. At 3 d after injury, VEGFa and 
HIF2- remain unchanged, whereas Angiopoietin-1, Angio-
poietin-2, and HIF1- trend toward decreased expression in 
Abcg2
/ muscle (Fig. 9, C–G).
Impaired recruitment of macrophages to muscle after 
injury  can  have  a  negative  effect  on  muscle  regeneration 
(Arnold et al., 2007; Contreras-Shannon et al., 2007). The 
significant increase in Abcg2 expression correlates with re-
cruitment of bone marrow–derived cells, so we determined 
whether the immune response to muscle injury was impacted 
in Abcg2
/ muscle. The inflammatory response is character-
ized by two waves of macrophage infiltration: M1 macrophages 
that most Abcg2 progeny are resident endothelial cells within 
muscle, and a small number of Abcg2 progeny are derived 
from the hematopoietic lineage.
Abcg2-labeled, CD45-positive cells 
increase upon injury
Because Abcg2-expressing cells increase upon an induced 
muscle  injury,  we  further  extended  our  study  of  Abcg2- 
labeled cells to 5 d after muscle injury to understand which 
cell types may be positively regulating muscle regeneration. 
Similar to the profiles obtained using the anti-Abcg2 anti-
body (Fig. 1), the percentage of mononuclear cells that are 
FDG positive increases at 5 d after injury and subsequently, 
returns to uninjured levels by 30 d after injury (Fig. 8 A). This 
significant increase in Abcg2-labeled progeny could repre-
sent the proliferation of cells labeled in uninjured tissue, or 
it could represent an influx of cells from the peripheral blood 
in response to injury. To test these two possibilities, Abcg2-
marked cells were labeled with FDG and costained for anti-
bodies of interest at 5 d after muscle injury and then analyzed 
by flow cytometry. Compared with uninjured TA muscles, 
the relative percentage of CD31- and Sca-1–positive endo-
thelial cells within FDG-positive cells decreased in injured 
muscle (Fig. 8 B). However, the majority of FDG-positive 
cells at 5 d after injury were immunoreactive for CD45 and   
negative for Sca-1 (Fig. 8 C). CD45 and Sca-1 double-positive 
resident muscle cells increase upon injury (Polesskaya et al.,   
2003), whereas bone marrow–derived CD45-positive cells 
have been shown to traffic to skeletal muscle after injury 
(Rivier et al., 2004). We hypothesized that the influx of FDG 
and  CD45  double-positive  cells  upon  injury  are  derived 
from a lineage originating in the bone marrow not a resident   
muscle lineage, as they are negative for Sca-1. Because the 
inflammatory response precedes and supports myogenesis, 
we  reasoned  that  some  of  the  Abcg2-labeled,  bone  mar-
row–derived cells may be macrophages (Arnold et al., 2007; 
Tidball and Wehling-Henricks, 2007; Tidball and Villalta, 
2010). Thus, we asked whether the muscle injury-induced, 
Abcg2-labeled cells included macrophages. At 5 d after in-
jury, we detected coexpression by immunofluorescence of 
the Abcg2-responsive reporter gene -galactosidase and the 
Table II.  Abcg2-labeled cell populations in uninjured skeletal muscle
Cell type Markers FDG+ cells
%
Endothelial cells CD31+, Sca1+, 7-integrin+ 79 ± 5
Bone marrow–derived cells CD45+ 10 ± 2
Myogenic cells
a,b CD31, Sca1, 7-integrin+ <1
FAPs
b,c CD31, CD45, Sca1+, PDGF-R-+ <1
Other muscle progenitor cells
d,e CD45, Sca1+, CD34+ <20
Values are means ± SEM; n = 3–6 independent experiments.
aBlanco-Bose et al., 2001.
bJoe et al., 2010.
cUezumi et al., 2010.
dTamaki et al., 2002.
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macrophages may be negatively impacted in Abcg2
/ mus-
cle. Consistent with this observation, we find that expression 
of TNF- and IL-6, both proinflammatory cytokines that in-
hibit M2 macrophage recruitment (Zádor et al., 2001; Warren 
et al., 2002), trend toward increased expression in Abcg2
/ 
muscle (Fig. 10, D and E). Additionally, CCL2 (MCP-1), a 
chemotactic and activating factor for macrophages that has 
been shown to be important for muscle regeneration (Shireman   
et al., 2007), trends toward decreased expression in Abcg2
/ 
muscle (Fig. 10 F).
are recruited as part of a proinflammatory (Th1) response and 
peak at 2–3 d after injury. This is followed closely by an anti-
inflammatory (Th2) response in which M2 macrophages are 
recruited and peak between 4 and 6 d after injury (Tidball and 
Villalta, 2010). We assessed the total number of macrophages 
during both phases. No difference in macrophage number is 
detected in uninjured tissue or at 3 d after injury (Fig. 10,   
A and C; and not depicted). However, 30% fewer macro-
phages are found in Abcg2
/ muscle at 5 d after injury (Fig. 10, 
B and C), suggesting that recruitment of antiinflammatory M2 
Figure 8.  Abcg2-labeled cells that are CD45 positive increase at 5 d after BaCl2-induced injury. Cells labeled with FDG were analyzed via flow cytometry. 
(A) Representative dot plots show FDG versus side scatter for cells isolated from injured TA muscles at 5 and 30 d postinjury (dpi) and the respective con-
tralateral uninjured TA muscles. Gated regions indicate the percentage of FDG+ cells. (B and C) FDG+ cells from uninjured (left) and 5 d after injury TA 
muscles (right) were gated for CD31 versus Sca-1 (B) and CD45 versus Sca-1 (C). As a fraction of the FDG-labeled cells, endothelial cells decrease (CD31+ 
and Sca-1+; top right quadrant in B) and CD45+ (Sca-1; bottom right quadrant in C) bone marrow–derived cells increase at 5 d after injury relative to 
uninjured control. Dot plots shown are representative of four experiments. Numbers correspond to the percentage of positive cells in the given quadrant. 
(D) Tissue sections from 5 d after injury TA muscle were stained for -galactosidase (-gal) and the macrophage marker F4/80. Arrows indicate cells that 
coexpress -galactosidase and F4/80 (yellow). APC, allophyrocyanin; PE, phycoerythrin. Bars, 50 µm.JCB • VOLUME 195 • NUMBER 1 • 2011   158
endothelial cells and pericytes in uninjured tissue. Furthermore, 
upon muscle injury, Abcg2-expressing cells increase, and Abcg2 
progeny include infiltrating cells from the peripheral blood, of 
which some are macrophages. The recruitment of circulating 
cells to muscle after injury is impaired in Abcg2
/ mice.
Abcg2 labeling gives rise to vascular-
associated cells within skeletal muscle
Based on the conditional expression of the LacZ reporter gene, 
we show that Abcg2-marked cells generate numerous interstitial 
Discussion
Expression of the ABC transporter Abcg2 is the major molecular 
determinant of the SP phenotype in skeletal muscle and in other 
cells, including cells in the hematopoietic lineage and heart tis-
sue (Zhou et al., 2002; Martin et al., 2004; Meeson et al., 2004). 
In this study, we demonstrate that upon genetic loss of Abcg2,   
in which SP cells are depleted, skeletal muscle regeneration is 
delayed. We further show that in skeletal muscle, Abcg2-marked 
cells give rise to multiple interstitial cell types, including   
Figure 9.  Formation of new capillaries is unperturbed, but angiogenic signaling is disrupted in Abcg2
/ mice. (A) VE-cadherin staining indicates similar 
capillary density between Abcg2
+/+ and Abcg2
/ muscle after injury. Bar, 50 µm. (B) Capillary density was determined by scoring the total positive pixel 
area for VE-cadherin per field. Values are means ± SEM; n = 3. (C–G) Quantitative RT-PCR for VEGFa (C), Angiopoietin-1 (D), Angiopoietin-2 (E), HIF1- (F), 
and HIF2- (G) was performed on RNA isolated from uninjured (UI) TA and 3 d postinjury (dpi) TA muscles (n = 3). WT, wild type; KO, knockout.159 Abcg2 lineage tracing in skeletal muscle • Doyle et al.
Sca-1  (CD45  negative),  which  likely  includes  SP  cells  and   
possibly,  other  muscle-derived  stem  cells  or  myoendothelial 
cells (Tamaki et al., 2002; Zheng et al., 2007; Péault et al., 2007).
Upon injury, we observe a significant increase in the per-
centage of Abcg2-labeled cells. Unlike in uninjured tissue in 
which the majority of labeled cells are CD45 negative, upon 
injury, the majority of Abcg2 progeny are CD45 positive. Fur-
thermore, a subset of Abcg2 progeny is positive for the mac-
rophage  marker  F4/80.  Upon  injury,  bone  marrow–derived 
cells, including circulating monocytes, which differentiate into 
macrophages, are recruited to the muscle where they participate 
in the inflammatory process and promote regeneration (Rivier   
et al., 2004; Arnold et al., 2007). Hematopoietic lineage pro-
genitors also express Abcg2; therefore, it is possible that the   
observed increase in Abcg2-positive cells upon injury results from 
circulating cells infiltrating the muscle tissue. In support of this 
hypothesis, circulating cells derived from hematopoietic stem 
cells are labeled by Abcg2. Using a conditional Rosa26-YFP 
reporter, YFP is detected in circulating cells expressing GR1 
and Mac1, surface antigens of monocytes (unpublished data). 
cell types in skeletal muscle. SP cells comprise 1–2% of inter-
stitial cells within skeletal muscle. Although Abcg2 is expressed 
by SP cells, we find that Abcg2 progeny include 20–50% of mus-
cle interstitial cells. Specifically, a large majority of endothelial 
cells and some pericytes, based on -galactosidase coexpression 
with CD31 and NG2, are derived from an Abcg2-positive progen-
itor cell, which is consistent with the previous observation that 
Abcg2-positive cells are located in close proximity to the vas-
culature (Meeson et al., 2004). Additionally, we show expres-
sion  of  Sca-1  and  7-integrin  with  the  majority  of  Abcg2 
progeny and expression of CD34 with a minority of Abcg2 
progeny. Isolated myogenic progenitor cells express both CD34 
and 7-integrin (Sca-1 and CD31 negative; Beauchamp et al., 
2000; Blanco-Bose et al., 2001; Montarras et al., 2005; Joe   
et al., 2010) and recently identified that fibrogenic and adipo-
genic  progenitors express PDFG-R- and Sca-1 (CD45 and 
CD31 negative; Joe et al., 2010; Uezumi et al., 2010). Based   
on these markers, we find that few myogenic progenitors or 
FAPS are derived from Abcg2 progeny. We do find that a small 
population  of Abcg2-derived  cells  is  positive  for  CD34  and   
Figure 10.  The antiinflammatory immune response is disrupted in Abcg2
/ mice. (A and B) Staining with the macrophage marker F4/80 with and 
without laminin is shown for tissue sections 3 d (A) and 5 d (B) after BaCl2-induced injury. Bars, 50 µm. (C) Sections were scored for F4/80-positive cells. 
Values shown are means ± SEM; P < 0.01 for 5 d postinjury (dpi); n = 3 mice per genotype for each time point. (D–F) Quantitative RT-PCR for TNF- (D), 
IL-6 (E), and CCL2 (F) was performed on RNA isolated from uninjured (UI) TA and 3 d after injury TA muscles (n = 3). WT, wild type; KO, knockout.JCB • VOLUME 195 • NUMBER 1 • 2011   160
(muscle-loading model) leads to impaired muscle regeneration 
as measured by central nucleation and impaired satellite cell 
differentiation (Tidball and Wehling-Henricks, 2007).
In addition, there may be functional compensation from 
other ABC transporters. Functional compensation by ABC trans-
porters is known to occur; for example, Abcg2 can compensate 
for loss of mdr1a/1b in hematopoietic stem cells (Zhou et al., 
2001). Both mdr1a/1b are expressed in mouse skeletal muscles 
and could provide compensation for Abcg2 loss in some cir-
cumstances (Croop et al., 1989; Israeli et al., 2004).
Impaired skeletal muscle regeneration in Abcg2
/ mice 
is consistent with a previously identified role for Abcg2 in tis-
sue defense and organ regeneration. In hematopoietic stem cells 
and cardiac progenitor cells, Abcg2 provides an important cell 
survival advantage under hypoxic conditions (Krishnamurthy 
et al., 2004; Martin et al., 2008). Moreover, a recent study 
demonstrated that Abcg2 has a critical function in cardiac   
repair after myocardial infarction; specifically, impaired sur-
vival of microvascular endothelial cells lead to cardiac rupture 
in Abcg2
/ mice (Higashikuni et al., 2010). Unlike this myocar-
dial infarction model, the microvasculature appears to be un-
affected after injury of skeletal muscle with BaCl2. However, 
the  myocardial  infarction  model  is  a  more  severe  injury,   
and the roles of Abcg2 may be slightly different in the heart 
and skeletal muscle. Nonetheless, it is likely that Abcg2 pro-
vides a critical cell survival function, either through its ability 
to export genotoxic substrates from the cell or through an   
unknown  novel  mechanism  in  which  the  ABC  transporter   
affects signaling between cells. This is an attractive hypothesis 
because  cell-autonomous  defects  in  satellite  cells  from 
Abcg2
/ mice do not appear to account for the defects ob-
served during regeneration in vivo. Moreover, cells derived 
from  Abcg2-marked  cells,  including  endothelial  cells  and 
macrophages, are known to positively regulate myogenesis, 
and we observe defects in the macrophage response. Addi-
tionally, endothelial cells stimulate growth of satellite cells 
through the secretion of a variety of growth factors, including 
IGF-1,  VEGF,  FGF-2,  PDGF-BB,  and  hepatocyte  growth 
factor (Christov et al., 2007). Consistently, we observe mod-
est decreases in angiogenic factors, including HIF1-, and 
the angiopoietin genes that could contribute to disrupted sig-
naling during regeneration. The immune response is critical 
to healthy muscle regeneration, and macrophages have been 
shown to enhance satellite cell growth and protect satellite 
cells  from  apoptosis  (Chazaud  et  al.,  2003;  Sonnet  et  al., 
2006). The inflammatory response to muscle injury is com-
plex, involving two distinct waves of macrophage infiltration, 
both proinflammatory and antiinflammatory, that secret cyto-
kines with differing effects on myogenesis and muscle re-
generation  (Tidball  and  Villalta,  2010).  Interestingly,  the 
proinflammatory  cytokines  TNF-  and  IL-6  are  increased, 
and the chemotactic and activating cytokine CCL-2, which 
has  been  previously  shown  to  affect  muscle  regeneration   
(Zádor et al., 2001; Warren et al., 2005; Shireman et al., 2007; 
Martinez et al., 2010), is decreased in Abcg2
/ muscle. The 
specific effect of loss of Abcg2 on the antiinflammatory phase 
of the immune response correlates with the peak in Abcg2 
Based on these observations, we propose that Abcg2 labels two 
distinct populations of cells: (1) resident muscle interstitial cells 
and (2) circulating progenitor cells that traffic to skeletal muscle 
upon injury.
Abcg2+ cells are not a significant source of 
myogenic progenitors
Previous studies have proposed that SP cells prospectively iso-
lated from skeletal muscle possess myogenic activity and thus, 
may either contribute to renewal of the satellite cell population 
or may be an independent progenitor cell (Asakura et al., 2002; 
Tanaka et al., 2009). Our lineage tracing data using the Abcg2 
locus to drive expression of CreERT2 suggests that Abcg2- 
labeled cells possess limited myogenic activity. A few possi-
bilities may account for the low contribution of Abcg2 labeling 
to new myofibers in our study. (a) Prior studies demonstrated 
the ability of isolated SP cells to contribute to generation of new 
myofibers upon intramuscular transplantation (Asakura et al., 
2002; Meeson et al., 2004). The manipulation of isolated cells 
for transplantation may alter the properties of SP cells such that 
they can undergo myogenic differentiation. Alternatively, the 
transplant procedure could give the SP cells a competitive ad-
vantage over endogenous satellite cells. (b) The Abcg2-labeled 
cells that contribute to myofibers may come from bone marrow 
cells. Previous studies have shown that bone marrow–derived 
cells, including SP cells, differentiate to myogenic cells at a 
low frequency (Ferrari et al., 1998; Gussoni et al., 1999; Ojima   
et al., 2004; Luth et al., 2008). These observations are consis-
tent with the low Abcg2 labeling of regenerated myofibers we   
detect when injuries are performed concurrently with tamoxi-
fen treatment such that the Abcg2 and CD45 double-positive 
cells are also labeled. (c) The level of CreERT2 expression 
from the Abcg2 locus in SP cells may be below the threshold 
required for efficient Cre-mediated recombination. In hema-
topoietic stem cells, detection of the conditional Rosa26-YFP 
reporter is low (unpublished data) despite the firmly established 
expression of Abcg2 in hematopoietic stem cells (Zhou et al., 
2001, 2002).
Loss of Abcg2 results in impaired  
muscle regeneration
In an injury-induced model of muscle regeneration, genetic loss 
of Abcg2 leads to reduced myogenic proliferation and reduced 
numbers of myofibers expressing eMyHC. This phenotype is 
consistent with a loss of total myonuclei, reduced centrally nu-
cleated myofibers, and reduced myofiber size as well as a loss of 
Pax7+ satellite cells at 30 d after injury. Although the impaired 
regeneration phenotype in Abcg2
/ mice is not as severe as 
other models of impaired skeletal muscle regeneration in which 
both the immune response and angiogenesis are impaired, such 
as the CCR2-null mice (Contreras-Shannon et al., 2007; Ochoa 
et al., 2007), it is reminiscent of the resulting impaired muscle 
regeneration upon partial depletion of monocytes and macro-
phages (Arnold et al., 2007) or loss of CCL2 (MCP-1; Martinez 
et al., 2010). Consistent with partial depletion of macrophages,   
we observe a specific effect on recruitment of antiinflamma-
tory (M2) macrophages. Inhibition of macrophages at day 4 161 Abcg2 lineage tracing in skeletal muscle • Doyle et al.
(Genetex) at 1:500, mouse anti-Pax7 (Developmental Studies Hybridoma 
Bank) at 1:100, rabbit anti-MyoD (Santa Cruz Biotechnology, Inc.) at 1:800, 
and mouse monoclonal eMyHC (Developmental Studies Hybridoma Bank), 
neat.  For  eMyHC  and  Pax7  staining,  a  fluorescein  immunodetection  kit 
(Mouse on Mouse; Vector Laboratories) was used per the manufacturer’s   
directions. Secondary antibodies conjugated with Alexa Fluor 488, Alexa 
Fluor 555, or Alexa Fluor 594 (Invitrogen) were used at a 1:1,000 dilution. 
Vectashield with DAPI (Vector Laboratories) was used as mounting media.
Morphometric analysis
Myofiber cross-sectional area, number of myonuclei, and number of BrdU-
positive cells in injured TA muscle were quantified via manual masking   
using SlideBook (Intelligent Imaging Innovations) based on dystrophin or BrdU 
and DAPI staining in 40× fields. The number of satellite cells was quantified 
based on Pax7 staining and sublaminar localization. A minimum of 500 
myofibers and three sections were analyzed per biological replica.
Flow cytometry
Primary muscle cells were isolated from adult mouse hind-limb muscles or 
TA muscles as previously described (Tanaka et al., 2009). In brief, isolated 
muscle was digested with type I collagenase (Worthington) for 1 h at 
37°C, filtered, and recovered in F12-C with 15% horse serum and 0.5 nM 
FGF-2. For antibody labeling, cells were incubated for 45 min at 4°C with 
mouse Abcg2 (Bcrp1, clone 5D3; BD) at 1:100 followed by anti–mouse 
IgG–PE-Cy5  (Santa  Cruz  Biotechnology,  Inc.)  secondary  antibody.  For 
FDG (Invitrogen) labeling, an equal volume of cells and 2 mM FDG were 
mixed and incubated at 37°C for 1 min. 10 vol cold media was added, 
and cells were recovered on ice for 1 h. Cells were then incubated with the 
following antibodies at 4°C for 30 min: rat anti–Sca-1–PE conjugated (BD) 
at 1:200, rat anti-CD31–PE conjugated (BD) at 1:200, rat anti-CD45–
PeCy7 conjugated (BD) at 1:400, rat anti–7-integrin–Alexa Fluor 647 
conjugated (AbLab, University of British Columbia) at 1:1,000, rat anti-
CD34–Alexa Fluor 647 (BD) conjugated at 1:100, and rat anti-PDGF-R-–
allophycocyanin conjugated (eBioscience) at 1:200. DAPI was added at   
1 µg/ml to exclude dead cells. Cell analysis was performed with an ADP 
three-laser flow cytometer (CyAn; Beckman Coulter). Appropriate fluores-
cence minus one controls were used to set gates to <1% background. Data 
were analyzed after sort with FlowJo software (Tree Star).
RNA isolation and quantitative RT-PCR
TA muscles 3 d after BaCl2-induced injury and uninjured contralateral con-
trol from wild-type and Abcg2
/ mice were harvested and homogenized, 
and RNA was isolated using a purification kit (RNAqueous; Invitrogen). 
cDNA was made using reverse transcriptase (Superscript III; Invitrogen) 
with random hexamer primers, and quantitative PCR was performed using 
SYBR green (Applied Biosystems) and gene specific primers as previously 
published (Higashikuni et al., 2010).
Microscopy, image processing, and figure preparation
Brightfield  images  were  acquired  with  a  microscope  (DM5500;  Leica)   
using Metamorph software (Molecular Devices) coupled with a camera 
(DFC; Leica). Objectives used were HC Plan Apochromat 20×/NA 0.70 
or  HCX  Plan  Apochromat  40×  oil/NA  1.25–0.75  (Leica).  Fluorescent   
micrographs were taken with a confocal microscope (LSM 5; Carl Zeiss)   
using ZEN 2009 software (Carl Zeiss) or with an epifluorescence micro-
scope (Eclipse E800; Nikon) using SlideBook v4.1 acquisition software 
coupled  to  a  digital  camera  (Sensicam;  Cooke).  Lenses  used  with  the 
confocal microscope were Plan Apochromat 63× oil/NA 1.4 differential   
interference contrast M27 (Carl Zeiss). Lenses used with the epifluorescence 
microscope were Plan Fluor either 40×/NA 0.75 differential interference 
contrast  M  or  20×/NA  0.50  Ph1  DLL  (Nikon).  All  digital  microscopic   
images were acquired at room temperature. Mounting medium (Vecta-
shield) was used for imaging. The fluorochromes used were Alexa Fluor 
488 and Alexa Fluor 594 or Alexa Fluor 555 (confocal) conjugated to sec-
ondary antibodies for immunofluorescence as indicated in the Immuno-
fluorescence section. For figure preparation, images were exported in   
Photoshop (Adobe), if necessary, brightness and contrast were adjusted for 
the entire image, the image was cropped, and individual color channels 
were extracted (when required) without color correction or  adjustments.
Statistical analysis
All data are presented as means ± SEM. Student’s t test (unpaired and two 
tailed) was used to determine the statistical significance of individual data-
sets in Prism (version 5; GraphPad Software). Differences are considered 
significant for P < 0.05, very significant for P < 0.01, and highly significant 
for P < 0.001.
expression at 5 d after injury. Together, these data suggest a 
role for Abcg2 during muscle regeneration in which it affects 
signaling between inflammatory and myogenic cells.
Although the mechanism of Abcg2 function remains to be 
uncovered, here, we demonstrate a physiologically significant 
function for Abcg2 in regeneration of skeletal muscle. These 
data highlight the involvement of Abcg2 in a complex biological 
process involving organ regeneration. Furthermore, these find-
ings contribute to the emerging consensus of muscle healing 
as a system in which nonmyogenic cells, namely endothelial 
cells, immune cells, and others, play a critical role in skeletal 
muscle regeneration.
Materials and methods
Mice
Mice were housed and bred according to National Institutes of Health guide-
lines for the ethical treatment of animals in a pathogen-free facility. All proce-
dures and protocols were approved by the Institutional Animal Care and Use 
Committee at the University of Colorado.
Abcg2
CreERT2 (unpublished data) crossed to the conditional Rosa26-
LacZ reporter, Abcg2 knockout mice (Zhou et al., 2002), and mdx
4cv  
(Im et al., 1996) were used. Control mice used were littermate wild-type 
mice. For injury of the TA muscle, mice were anesthetized, and the right TA 
muscle was injected with 60 µl of 1.2% BaCl2 (Caldwell et al., 1990) in three 
places along the muscle. Tamoxifen was prepared at 20 mg/ml in 5% etha-
nol and sterile maize oil and administered via i.p. injection for a consecutive 
3 d at 75 mg per kilogram of mouse weight per day. 10 mg/ml BrdU was in-
jected i.p. 1 h before sacrifice at 50 mg per kilogram of mouse weight.
X-gal staining
Upon harvest, TA muscles were fixed with 4% PFA (in PBS) for 2 h on ice, 
rinsed with PBS, equilibrated overnight in 30% sucrose, and embedded in 
optimal cutting temperature freezing medium. Slides with 8-µm sections were 
processed for X-gal staining. Tissue was postfixed with 0.2% PFA, washed 
with PBS containing 2 mM MgCl2, and washed with X-gal detergent rinse 
(0.1 M phosphate buffer, pH 7.3, 2 mM MgCl2, 0.01% Na deoxycholate, 
and 0.02% IGEPAL CA-630) each for 10 min on ice. Tissue was stained 
overnight with 1 mg/ml X-gal in detergent rinse containing 20 mM Tris,   
pH 7.3, 5 mM potassium ferricyanide, and 5 mM potassium ferrocyanide. 
Sections were counterstained with nuclear fast red and imaged via brightfield 
microscopy. For X-gal–positive cell scoring, a minimum of three sections were 
analyzed per biological replica.
Primary cell culture
Satellite cells were obtained as previously described (Pisconti et al., 2010). 
In brief, hind-limb muscles from 3–6-mo-old mice were harvested, digested 
with collagenase type I (Worthington) for 1 h at 37°C, filtered, and cul-
tured on gelatin-coated plates in growth medium (F12-C + 15% horse serum 
+ 20 ng/ml FGF-2). For MyHC staining of primary cultures, cells were fixed 
with AFA (60% EtOH, 3% formaldehyde, and 4% glacial acetic acid). 
Anti–mouse MyHC (clone MF20; Developmental Studies Hybridoma Bank) 
was used at 1:10 with anti–mouse biotin-conjugated secondary antibody 
followed by incubation for 30 min with Vectastain ABC reagent (Vector 
Laboratories) and developed with DAB (Vector Laboratories). For primary 
cell scoring, a minimum of 10 fields were scored for Pax7 and MyoD. For 
fusion index scoring, the total number of myonuclei in MyHC-positive myo-
tubes and the total number of nuclei were counted.
Immunofluorescence
Tissue sections and satellite cells were prepared as previously described 
from 3–6-mo-old mice (Olguin et al., 2007; Pisconti et al., 2010). For detec-
tion of labeled DNA, tissue sections were fixed in methanol for 10 min at 
20°C, washed in PBS, permeabilized in PBS + 0.2% Triton X-100 + 1% 
BSA for 10 min, and denatured in 3 M HCl for 20 min before incubation 
with primary antibodies overnight at 4°C in PBS + 10% horse serum. 
Primary antibodies used for immunofluorescence were chicken polyclonal   
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